{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:29:13Z","timestamp":1789684153207,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medico- Engineering Cooperation Funds from University of Electronic Science and Technology of China","award":["ZYGX2021YGLH209"],"award-info":[{"award-number":["ZYGX2021YGLH209"]}]},{"name":"Foundation for Sichuan Provincial People\u2019s Hospital","award":["2021LY03"],"award-info":[{"award-number":["2021LY03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gliomas account for about 80% of all malignant brain and other central nervous system (CNS) tumors. Temozolomide (TMZ) resistance represents a major treatment hurdle. Adrenomedullin (ADM) has been reported to induce glioblastoma cell growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cell viability was measured using the CCK-8 assay. The apoptosis analysis was performed using the Annexin V-FITC Apoptosis Detection Kit. The mitochondrial membrane potential was determined by JC-1 staining. A nude mouse tumor assay was used to detect tumor formation. Hematoxylin and eosin (H&amp;E) and immunohistochemical (IHC) staining were performed in tissue sections. Activation of Akt and Erk and expression of apoptosis-related proteins were determined by immunoblotting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ADM expression has been found upregulated in TMZ -resistant glioma samples based on bioinformatics and experimental analyses. Knocking down ADM in glioma cells enhanced the suppressive effects of TMZ on glioma cell viability, promotive effects on cell apoptosis, and inhibitory effects on mitochondrial membrane potential. Moreover, ADM knockdown also enhanced TMZ effects on Bax\/Bcl-2, Akt phosphorylation, and Erk1\/2 phosphorylation. Bioinformatics and experimental investigation indicated that miR-1297 directly targeted ADM and inhibited ADM expression. miR-1297 overexpression exerted similar effects to ADM knockdown on TMZ-treated glioma cells. More importantly, under TMZ treatment, inhibition of miR-1297 attenuated TMZ treatment on glioma cells; ADM knockdown partially attenuated the effects of miR-1297 inhibition on TMZ-treated glioma cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>miR-1297 sensitizes glioma cells to TMZ treatment through targeting ADM. The Bax\/Bcl-2, Akt, and Erk1\/2 signaling pathways, as well as mitochondrial functions might be involved.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03647-6","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T19:03:54Z","timestamp":1664651034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM)"],"prefix":"10.1186","volume":"20","author":[{"given":"Zongze","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-8359","authenticated-orcid":false,"given":"Jian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"3647_CR1","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, Reifenberger G. Glioma. Nat Rev Dis Primers. 2015;1:15017.","journal-title":"Nat Rev Dis Primers"},{"key":"3647_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas\u2014implications for classification and therapy. Nat Rev Clin Oncol. 2017;14:434\u201352.","journal-title":"Nat Rev Clin Oncol"},{"key":"3647_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M. Society NOASGoN-oWGoGC: temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13:707\u201315.","journal-title":"Lancet Oncol"},{"key":"3647_CR4","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1200\/JCO.2015.61.5005","volume":"33","author":"T Sandmann","year":"2015","unstructured":"Sandmann T, Bourgon R, Garcia J, Li C, Cloughesy T, Chinot OL, Wick W, Nishikawa R, Mason W, Henriksson R, Saran F, Lai A, Moore N, Kharbanda S, Peale F, Hegde P, Abrey LE, Phillips HS, Bais C. Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial. J Clin Oncol. 2015;33:2735\u201344.","journal-title":"J Clin Oncol"},{"key":"3647_CR5","doi-asserted-by":"publisher","first-page":"23345","DOI":"10.1074\/jbc.271.38.23345","volume":"271","author":"MJ Miller","year":"1996","unstructured":"Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, Cuttitta F. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem. 1996;271:23345\u201351.","journal-title":"J Biol Chem"},{"key":"3647_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0002-9440(10)62555-2","volume":"160","author":"L Ouafik","year":"2002","unstructured":"Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brunner N, Martin PM. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol. 2002;160:1279\u201392.","journal-title":"Am J Pathol"},{"key":"3647_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1442-2042.2002.00469.x","volume":"9","author":"Y Fujita","year":"2002","unstructured":"Fujita Y, Mimata H, Nasu N, Nomura T, Nomura Y, Nakagawa M. Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma. Int J Urol. 2002;9:285\u201395.","journal-title":"Int J Urol"},{"key":"3647_CR8","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/sj.onc.1205374","volume":"21","author":"MK Oehler","year":"2002","unstructured":"Oehler MK, Hague S, Rees MC, Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene. 2002;21:2815\u201321.","journal-title":"Oncogene"},{"key":"3647_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/hh1301.092498","volume":"89","author":"H Nishimatsu","year":"2001","unstructured":"Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Goto A, Kitamura T, Hirata Y. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase\/Akt-dependent pathway in rat aorta. Circ Res. 2001;89:63\u201370.","journal-title":"Circ Res"},{"key":"3647_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/01.CIR.0000109214.30211.7C","volume":"109","author":"H Okumura","year":"2004","unstructured":"Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C, Kangawa K. Adrenomedullin infusion attenuates myocardial ischemia\/reperfusion injury through the phosphatidylinositol 3-kinase\/Akt-dependent pathway. Circulation. 2004;109:242\u20138.","journal-title":"Circulation"},{"key":"3647_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI33302","volume":"118","author":"KL Fritz-Six","year":"2008","unstructured":"Fritz-Six KL, Dunworth WP, Li M, Caron KM. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest. 2008;118:40\u201350.","journal-title":"J Clin Invest"},{"key":"3647_CR12","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1038\/sj.onc.1204422","volume":"20","author":"MK Oehler","year":"2001","unstructured":"Oehler MK, Norbury C, Hague S, Rees MC, Bicknell R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene. 2001;20:2937\u201345.","journal-title":"Oncogene"},{"key":"3647_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fonc.2019.00463","volume":"9","author":"A Lo Dico","year":"2019","unstructured":"Lo Dico A, Valtorta S, Ottobrini L, Moresco RM. Role of metformin and AKT axis modulation in the reversion of hypoxia induced TMZ-resistance in glioma cells. Front Oncol. 2019;9:463.","journal-title":"Front Oncol"},{"key":"3647_CR14","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/stem.753","volume":"29","author":"A Sato","year":"2011","unstructured":"Sato A, Sunayama J, Matsuda K, Seino S, Suzuki K, Watanabe E, Tachibana K, Tomiyama A, Kayama T, Kitanaka C. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis. Stem Cells. 2011;29:1942\u201351.","journal-title":"Stem Cells"},{"key":"3647_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5732\/cjc.013.10170","volume":"32","author":"T Huang","year":"2013","unstructured":"Huang T, Alvarez A, Hu B, Cheng SY. Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer. 2013;32:582\u201393.","journal-title":"Chin J Cancer"},{"key":"3647_CR16","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1038\/ncomms12885","volume":"7","author":"T Huang","year":"2016","unstructured":"Huang T, Alvarez AA, Pangeni RP, Horbinski CM, Lu S, Kim SH, James CD, J Raizer J, A Kessler J, Brenann CW, Sulman EP, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, Cheng SY. A regulatory circuit of miR-125b\/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun. 2016;7:12885.","journal-title":"Nat Commun"},{"key":"3647_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5732\/cjc.011.10243","volume":"30","author":"H Ling","year":"2011","unstructured":"Ling H, Zhang W, Calin GA. Principles of microRNA involvement in human cancers. Chin J Cancer. 2011;30:739\u201348.","journal-title":"Chin J Cancer"},{"key":"3647_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5732\/cjc.012.10010","volume":"32","author":"B Liu","year":"2013","unstructured":"Liu B, Bao JK, Yang JM, Cheng Y. Targeting autophagic pathways for cancer drug discovery. Chin J Cancer. 2013;32:113\u201320.","journal-title":"Chin J Cancer"},{"key":"3647_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcp.22126","volume":"224","author":"S Cascio","year":"2010","unstructured":"Cascio S, D\u2019Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol. 2010;224:242\u20139.","journal-title":"J Cell Physiol"},{"key":"3647_CR20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.18632\/oncotarget.1165","volume":"4","author":"D Li","year":"2013","unstructured":"Li D, Ilnytskyy Y, Kovalchuk A, Khachigian LM, Bronson RT, Wang B, Kovalchuk O. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer. Oncotarget. 2013;4:1373\u201387.","journal-title":"Oncotarget"},{"key":"3647_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/imr.12043","volume":"253","author":"AY So","year":"2013","unstructured":"So AY, Zhao JL, Baltimore D. The Yin and Yang of microRNAs: leukemia and immunity. Immunol Rev. 2013;253:129\u201345.","journal-title":"Immunol Rev"},{"key":"3647_CR22","first-page":"4749","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Li W, Chen G, Huang J, Li W. MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level. Am J Transl Res. 2020;12:4749\u201356.","journal-title":"Am J Transl Res"},{"key":"3647_CR23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1080\/15548627.2019.1569947","volume":"15","author":"T Huang","year":"2019","unstructured":"Huang T, Wan X, Alvarez AA, James CD, Song X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B, Cheng SY. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy. Autophagy. 2019;15:1100\u201311.","journal-title":"Autophagy"},{"key":"3647_CR24","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.7150\/thno.33800","volume":"9","author":"W Huang","year":"2019","unstructured":"Huang W, Zhong Z, Luo C, Xiao Y, Li L, Zhang X, Yang L, Xiao K, Ning Y, Chen L, Liu Q, Hu X, Zhang J, Ding X, Xiang S. The miR-26a\/AP-2alpha\/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma. Theranostics. 2019;9:5497\u2013516.","journal-title":"Theranostics"},{"key":"3647_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2019.03.016","volume":"42","author":"J Yin","year":"2019","unstructured":"Yin J, Zeng A, Zhang Z, Shi Z, Yan W, You Y. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. EBioMedicine. 2019;42:238\u201351.","journal-title":"EBioMedicine"},{"key":"3647_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-020-1137-5","volume":"19","author":"C Lu","year":"2020","unstructured":"Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, Chen L, Lyu X, Shi Z, Yan W, You Y. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28.","journal-title":"Mol Cancer"},{"key":"3647_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-018-0618-0","volume":"11","author":"H Li","year":"2018","unstructured":"Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3\/Bcl2 signaling pathway. J Hematol Oncol. 2018;11:70.","journal-title":"J Hematol Oncol"},{"key":"3647_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41419-018-0350-2","volume":"9","author":"X Jin","year":"2018","unstructured":"Jin X, Cai L, Wang C, Deng X, Yi S, Lei Z, Xiao Q, Xu H, Luo H, Sun J. CASC2\/miR-24\/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8\/caspase-3. Cell Death Dis. 2018;9:318.","journal-title":"Cell Death Dis"},{"key":"3647_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41419-020-03113-5","volume":"11","author":"J Sun","year":"2020","unstructured":"Sun J, Ma Q, Li B, Wang C, Mo L, Zhang X, Tang F, Wang Q, Yan X, Yao X, Wu Q, Shu C, Xiong J, Fan W, Wang J. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt\/beta-catenin signaling pathway. Cell Death Dis. 2020;11:890.","journal-title":"Cell Death Dis"},{"key":"3647_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/mc.20659","volume":"49","author":"Z Guo","year":"2010","unstructured":"Guo Z, Zhang W, Xia G, Niu L, Zhang Y, Wang X, Zhang Y, Jiang B, Wang J. Sp1 upregulates the four and half lim 2 (FHL2) expression in gastrointestinal cancers through transcription regulation. Mol Carcinog. 2010;49:826\u201336.","journal-title":"Mol Carcinog"},{"key":"3647_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/ijms20010103","volume":"20","author":"US Kosgodage","year":"2018","unstructured":"Kosgodage US, Uysal-Onganer P, MacLatchy A, Kraev I, Chatterton NP, Nicholas AP, Inal JM, Lange S. Peptidylarginine deiminases post-translationally deiminate prohibitin and modulate extracellular vesicle release and micrornas in glioblastoma multiforme. Int J Mol Sci. 2018;20:103.","journal-title":"Int J Mol Sci"},{"key":"3647_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.675498","volume":"12","author":"L Cen","year":"2021","unstructured":"Cen L, Liu R, Liu W, Li Q, Cui H. Competing endogenous RNA networks in glioma. Front Genet. 2021;12: 675498.","journal-title":"Front Genet"},{"key":"3647_CR33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.7150\/thno.21740","volume":"8","author":"X Liu","year":"2018","unstructured":"Liu X, Zheng J, Xue Y, Yu H, Gong W, Wang P, Li Z, Liu Y. PIWIL3\/OIP5-AS1\/miR-367-3p\/CEBPA feedback loop regulates the biological behavior of glioma cells. Theranostics. 2018;8:1084\u2013105.","journal-title":"Theranostics"},{"key":"3647_CR34","first-page":"6576","volume":"8","author":"Y Guan","year":"2015","unstructured":"Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Int J Clin Exp Pathol. 2015;8:6576\u201388.","journal-title":"Int J Clin Exp Pathol"},{"key":"3647_CR35","doi-asserted-by":"publisher","first-page":"10581","DOI":"10.2147\/CMAR.S202247","volume":"11","author":"C Wang","year":"2019","unstructured":"Wang C, Huang S, Rao S, Hu J, Zhang Y, Luo J, Wang H. Decreased expression of miR-410-3p correlates with poor prognosis and tumorigenesis in human glioma. Cancer Manag Res. 2019;11:10581\u201392.","journal-title":"Cancer Manag Res"},{"key":"3647_CR36","doi-asserted-by":"publisher","first-page":"153303381985413","DOI":"10.1177\/1533033819854132","volume":"18","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang J, An W, Chen C, Wang W, Zhu C, Chen F, Chen H, Zheng W, Gong J. MiR-32 inhibits proliferation and metastasis by targeting EZH2 in glioma. Technol Cancer Res Treat. 2019;18:1533033819854132.","journal-title":"Technol Cancer Res Treat"},{"key":"3647_CR37","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1002\/cam4.3186","volume":"9","author":"J Wu","year":"2020","unstructured":"Wu J, Li R, Li L, Gu Y, Zhan H, Zhou C, Zhong C. MYC-activated lncRNA HNF1A-AS1 overexpression facilitates glioma progression via cooperating with miR-32-5p\/SOX4 axis. Cancer Med. 2020;9:6387\u201398.","journal-title":"Cancer Med"},{"key":"3647_CR38","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.18632\/aging.202923","volume":"13","author":"L Liu","year":"2021","unstructured":"Liu L, Li X, Shi Y, Chen H. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297\/EZH2 axis. Aging (Albany NY). 2021;13:12129\u201342.","journal-title":"Aging (Albany NY)"},{"key":"3647_CR39","first-page":"2149","volume":"8","author":"J Wang","year":"2016","unstructured":"Wang J, Xu X, Mo S, Tian Y, Wu J, Zhang J, Zhao J. Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro. Am J Transl Res. 2016;8:2149\u201358.","journal-title":"Am J Transl Res"},{"key":"3647_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4149\/neo_2020_200702N682","volume":"68","author":"D Song","year":"2021","unstructured":"Song D, Ye L, Xu Z, Jin Y, Zhang L. CircRNA hsa_circ_0030018 regulates the development of glioma via regulating the miR-1297\/RAB21 axis. Neoplasma. 2021;68:391\u2013403.","journal-title":"Neoplasma"},{"key":"3647_CR41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s13577-019-00316-7","volume":"33","author":"H Li","year":"2020","unstructured":"Li H, Yuan H. MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2. Hum Cell. 2020;33:619\u201329.","journal-title":"Hum Cell"},{"key":"3647_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1615\/CritRevNeurobiol.v11.i2-3.40","volume":"11","author":"SJ Wimalawansa","year":"1997","unstructured":"Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol. 1997;11:167\u2013239.","journal-title":"Crit Rev Neurobiol"},{"key":"3647_CR43","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.bone.2008.07.003","volume":"43","author":"D Naot","year":"2008","unstructured":"Naot D, Cornish J. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone. 2008;43:813\u20138.","journal-title":"Bone"},{"key":"3647_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/dmrr.223","volume":"17","author":"E Ruzicska","year":"2001","unstructured":"Ruzicska E, Toth M, Tulassay Z, Somogyi A. Adrenomedullin and diabetes mellitus. Diabetes Metab Res Rev. 2001;17:321\u20139.","journal-title":"Diabetes Metab Res Rev"},{"key":"3647_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","volume":"166","author":"Y Hong","year":"2012","unstructured":"Hong Y, Hay DL, Quirion R, Poyner DR. The pharmacology of adrenomedullin 2\/intermedin. Br J Pharmacol. 2012;166:110\u201320.","journal-title":"Br J Pharmacol"},{"key":"3647_CR46","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s13311-019-00826-0","volume":"17","author":"KH Ho","year":"2020","unstructured":"Ho KH, Chen PH, Chou CM, Shih CM, Lee YT, Cheng CH, Chen KC. A key role of DNA damage-inducible transcript 4 (DDIT4) connects autophagy and GLUT3-mediated stemness to desensitize temozolomide efficacy in glioblastomas. Neurotherapeutics. 2020;17:1212\u201327.","journal-title":"Neurotherapeutics"},{"key":"3647_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1158\/1535-7163.MCT-20-0619","volume":"20","author":"L Huang","year":"2021","unstructured":"Huang L, Wang D, Feng Z, Zhao H, Xiao F, Wei Y, Zhang H, Li H, Kong L, Li M, Liu F, Zhang H, Zhang W. Inhibition of intermedin (Adrenomedullin 2) suppresses the growth of glioblastoma and increases the antitumor activity of temozolomide. Mol Cancer Ther. 2021;20:284\u201395.","journal-title":"Mol Cancer Ther"},{"key":"3647_CR48","first-page":"2161","volume":"56","author":"S Shimizu","year":"1996","unstructured":"Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, Otsuki Y, Matsuda H, Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 1996;56:2161\u20136.","journal-title":"Cancer Res"},{"key":"3647_CR49","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","volume":"275","author":"J Yang","year":"1997","unstructured":"Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129\u201332.","journal-title":"Science"},{"key":"3647_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13543776.2021.1837775","volume":"31","author":"I Mondal","year":"2021","unstructured":"Mondal I, Kulshreshtha R. Potential of microRNA based diagnostics and therapeutics in glioma: a patent review. Expert Opin Ther Pat. 2021;31:91\u2013106.","journal-title":"Expert Opin Ther Pat"},{"key":"3647_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-019-1121-0","volume":"19","author":"J Sun","year":"2020","unstructured":"Sun J, Li B, Shu C, Ma Q, Wang J. Functions and clinical significance of circular RNAs in glioma. Mol Cancer. 2020;19:34.","journal-title":"Mol Cancer"},{"key":"3647_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/cgt.2016.48","volume":"23","author":"L Saadatpour","year":"2016","unstructured":"Saadatpour L, Fadaee E, Fadaei S, Nassiri Mansour R, Mohammadi M, Mousavi SM, Goodarzi M, Verdi J, Mirzaei H. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther. 2016;23:415\u20138.","journal-title":"Cancer Gene Ther"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03647-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03647-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T03:55:51Z","timestamp":1701143751000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03647-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3647"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03647-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"27 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors confirm that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}